Tag: 62119-70-4

62119-70-4, 2-Benzofuranacetic acid is a benzofuran compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,62119-70-4

Exemplary step 1: benzofuran-2-yl-acetic acid methyl ester (“BFAA methyl ester”) synthesis; Benzofuran-2-yl-acetic acid (BFAA, defined as 1 part by weight; Ix mole fraction) was combined with toluene (approximately 4.3 parts by weight) and methanol (approximately 1.96 parts by weight) was added to form a solution. Concentrated (cone.) hydrochloric acid (approximately 0.28 parts by weight; 0.5x mole fraction) was added while controlling the temperature below about 25 C and the reaction mixture was stirred for several hours. The reaction was quenched with excess aqueous sodium bicarbonate solution. The aqueous layer was separated and the organic layer was washed with aqueous sodium chloride solution. The aqueous layer was separated and the organic product layer was concentrated under vacuum, hi this particular example. Heptane was added to the residue and concentrated under vacuum to yield the product BFAA methyl ester.

As the paragraph descriping shows that 62119-70-4 is playing an increasingly important role.

Reference£º
Patent; ARYX THERAPEUTICS; WO2007/11835; (2007); A2;,
Benzofuran – Wikipedia
Benzofuran | C8H6O – PubChem

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.62119-70-4,2-Benzofuranacetic acid,as a common compound, the synthetic route is as follows.

Example 49 Synthesis of N-[(benzofuran-2-yl)acetyl]alanine iso-butyl ester Following General Procedure I above, and using benzofuran-2-ylacetic acid (Maybridge) and alanine iso-butyl ester (prepared following General Procedure J above), the title compound was prepared. The reaction was monitored by tlc on silica gel and purification was by filtration as described in the general procedure. NMR data was as follows: 1H-nmr (CDCl3): delta = 7.51 (m, 1H), 7.44 (m, 1H), 7.25 (m, 2H), 6.67 (s, 1H), 4.60 (m, 1H), 3.87 (m, 2H), 3.77 (s, 2H), 1.88 (m, 1H), 1.38 (d, 3H), 0.87 (d, 6H). C17H21NO4 (MW = 303, Mass Spectroscopy (MH+ 304)). GENERAL PROCEDURE IP-EPC coupling P-EPC coupling employs an amino acid ester and a substituted acetic acid compound. The acetic acid derivative is well known in the art and is typically commercially available. The amino acid ester is prepared by conventional methods from the known and typically commercially available N-BOC amino acid as described in GENERAL PROCEDURE J below. Specifically, the appropriate amino ester free base (0.0346 mmols) and substituted phenylacetic acid (0.069 mmols) were dissolved in 2.0 mL CHCl3 (EtOH free), treated with 150 mg of P-EPC (0.87 meq./g) and the reaction was mixed for 4 days at 23C. The reaction was filtered through a plug of cotton, rinsed with 2.0 mL of CHCl3 and the filtrate evaporated under a stream of nitrogen. The purity of each sample was determined by 1H NMR and ranged from 50% to >95%. Between 8.0 and 15.0 mg of final product was obtained from each reaction and was tested without additional purification

As the paragraph descriping shows that 62119-70-4 is playing an increasingly important role.

Reference£º
Patent; Elan Pharmaceuticals, Inc.; ELI LILLY AND COMPANY; EP951464; (2005); B1;,
Benzofuran – Wikipedia
Benzofuran | C8H6O – PubChem